Novartis AG Common Stock (NVS)

Operating Cash Flow (Statement)

$5.89B

Quarterly · Period ending: · USD

NVS logo

NVS Operating Cash Flow (Statement)

Latest reported$5.89B
NVS Quarterly Cash from Operations ($1.31B → $5.89B)
High-resolution chart · PNG

NVS operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
5,888,054,192
3,676,000,000
2,253,702,452
6,571,000,000
6,664,000,000
3,645,000,000
4,193,000,000
6,286,000,000
4,875,000,000
2,265,000,000
2,547,000,000
5,378,000,000
3,576,000,000
2,957,000,000
4,111,000,000
4,721,000,000
3,755,000,000
1,649,000,000
3,884,000,000
4,925,000,000
4,132,000,000
2,130,000,000
4,005,000,000
3,156,000,000
3,961,000,000
2,528,000,000
3,540,000,000
4,562,000,000
3,111,000,000
2,412,000,000
3,766,000,000
4,050,000,000
3,942,000,000
2,514,000,000
3,408,000,000
3,586,000,000
3,582,000,000
2,045,000,000
3,591,000,000
3,231,000,000
3,111,000,000
1,542,000,000
4,157,000,000
3,126,000,000
2,910,000,000
1,704,000,000
5,205,000,000
4,011,000,000
3,341,000,000
1,341,000,000
4,450,000,000
4,379,000,000
2,517,000,000
1,828,000,000
4,627,000,000
4,066,000,000
2,985,000,000
2,516,000,000
4,722,000,000
4,234,000,000
3,446,000,000
1,907,000,000
4,577,000,000
3,227,000,000
2,956,000,000
3,307,000,000
4,466,000,000
3,154,000,000
2,618,000,000
1,953,000,000
3,283,000,000
2,876,000,000
1,870,000,000
1,740,000,000
-5,017,000,000
10,190,000,000
1,813,000,000
2,224,000,000
2,290,000,000
2,517,000,000
1,759,000,000
2,144,000,000
2,260,000,000
2,538,000,000
1,325,000,000
1,957,000,000
1,761,000,000
2,136,000,000
1,666,000,000
1,162,000,000
1,885,000,000
1,878,000,000
1,130,000,000
1,759,000,000
2,426,000,000
1,311,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.